244 related articles for article (PubMed ID: 36190854)
1. Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.
Horvat N; de Oliveira AI; Clemente de Oliveira B; Araujo-Filho JAB; El Homsi M; Elsakka A; Bajwa R; Martins GLP; Elsayes KM; Menezes MR
Radiographics; 2022 Oct; 42(6):1670-1689. PubMed ID: 36190854
[TBL] [Abstract][Full Text] [Related]
2. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention.
Yacoub JH; Hsu CC; Fishbein TM; Mauro D; Moon A; He AR; Bashir MR; Burke LMB
Abdom Radiol (NY); 2021 Aug; 46(8):3528-3539. PubMed ID: 33835223
[TBL] [Abstract][Full Text] [Related]
3. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
4. Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
Mehta N; Frenette C; Tabrizian P; Hoteit M; Guy J; Parikh N; Ghaziani TT; Dhanasekaran R; Dodge JL; Natarajan B; Holzner ML; Frankul L; Chan W; Fobar A; Florman S; Yao FY
Gastroenterology; 2021 Nov; 161(5):1502-1512. PubMed ID: 34331914
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
Kutlu R; Karatoprak S
J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
[TBL] [Abstract][Full Text] [Related]
8. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
9. Loco-regional hepatocellular carcinoma treatment services as a bridge to liver transplantation.
Schmitz S; Lurje G; Ulmer F; Andert A; Bruners P; Schulze-Hagen M; Neumann U; Schoening W
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):228-236. PubMed ID: 30718181
[TBL] [Abstract][Full Text] [Related]
10. Radiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imaging (Review).
Ye XD; Yuan Z; Zhang J; Yuan Z
Oncol Rep; 2017 Mar; 37(3):1337-1346. PubMed ID: 28184942
[TBL] [Abstract][Full Text] [Related]
11. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of hepatocellular carcinoma before liver transplantation].
Guba M; Angele M; Rentsch M; Jauch KW; Zachoval R; Kolligs F; Gerbes A; Bruns CJ
Chirurg; 2013 May; 84(5):385-90. PubMed ID: 23519379
[TBL] [Abstract][Full Text] [Related]
13. Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis.
Bauschke A; Altendorf-Hofmann A; Ardelt M; Kissler H; Tautenhahn HM; Settmacher U
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1819-1827. PubMed ID: 32356179
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
[TBL] [Abstract][Full Text] [Related]
15. Management of hepatocellular carcinoma.
Said A; Wells J
Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
[TBL] [Abstract][Full Text] [Related]
16. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA
Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224
[TBL] [Abstract][Full Text] [Related]
17. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?
Dirican A; Karakas S
J Gastrointest Cancer; 2020 Dec; 51(4):1148-1151. PubMed ID: 32839945
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection and liver transplantation for hepatocellular carcinoma.
Akoad ME; Pomfret EA
Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
[TBL] [Abstract][Full Text] [Related]
19. Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.
Vivarelli M; Montalti R; Risaliti A
World J Gastroenterol; 2013 Nov; 19(42):7316-26. PubMed ID: 24259963
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation and portal vein tumour thrombus: futile enterprise?
Bhangui P
Curr Opin Organ Transplant; 2022 Aug; 27(4):312-319. PubMed ID: 36354257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
